Risk factors of unfavorable prognosis of chronic hepatitis C

7Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

Aim. To investigate risk factors of unfavorable prognosis in patients with chronic hepatitis C (CHC), including liver cirrhosis (LC), decompensated cirrhosis, hepatocellular carcinoma (HCC), cryoglobulinemic vasculitis (CryoVas) and B-cell non-Hodgkin's lymphoma. Materials and methods. This was a retrospective study using data of 824 patients with CHC hospitalized between 2010 and 2016 in clinic named after E.M. Tareev. We used multivariate analysis including logistic regression to calculate odds ratios (ORs) for potential risk factors/predictors associated with unfavorable outcomes in patients with CHC. Results and discussion. The rate of LC, decompensated LC, HCC, serious CryoVas and B-cell lymphoma in patients with CHC was 39.1% (322/824), 14.0% (115/824), 2.8% (23/824), 5.2% (43/824) and 1.2% (10/824), respectively. After adjustment for sex and age the rate of LC, decompensated LC, HCC was 22.8, 8.0 and 1.5%, respectively. Annual rate of LC in patients with CHC was 1.5%; in cirrhotic patients annual rate of decompensated LC and HCC was 2.9 and 1%, respectively. Risk factors independently associated with development of LC were elevated body mass index (OR 1.43), immunosuppressive therapy (OR 1.67), diabetes type 2 (OR 2.03), absence of antiviral therapy (OR 2.15), alcohol abuse (OR 2.34), duration of infection ≥20 years (ÎR 2.74) and an absence of sustained virological responce (SVR) (OR 2.98). Independent risk factors for decompensation in cirrhotic patients included diabetes type 2 (OR 1.47), alcohol abuse (OR 1.53), an absence of antiviral therapy (OR 2.36) and an absence of SVR (OR 1.94). An episode of decompensation was the independent predictor of HCC in cirrhotic patients (OR 3.99). Genotype 1b (OR 1.66) and an absence of antiviral therapy (OR 3.31) were independently associated with serious CryoVas. Two prognostic scales were offered for risk evaluation of LC and its complications. Conclusions. Multivariate analysis showed several factors independently associated with higher risk for LC, decompensation of LC, HCC, serious CryoVas in patients with CHC. The rate of unfavorable outcomes of CHC is found, including rare extrahepatic manifestations.

References Powered by Scopus

Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013

6254Citations
N/AReaders
Get full text

EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma

5045Citations
N/AReaders
Get full text

Global epidemiology and genotype distribution of the hepatitis C virus infection

1543Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Polymorphisms rs763110 in FASL is linked to hepatitis C virus infection among high-risk populations

7Citations
N/AReaders
Get full text

Assessment of external risk factors of hepatocellular cancer development and markers of genetic predisposition to its development in the ethnic group of yakut-men

4Citations
N/AReaders
Get full text

Virus-related liver cirrhosis: clinical profile of a patient, thanatogenesis, and pathomorphology

2Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Shchanitcyna, S. E., Burnevich, E. Z., Nikulkina, E. N., Filatova, A. L., Мoiseev, S. V., & Ìukhin, N. A. (2019). Risk factors of unfavorable prognosis of chronic hepatitis C. Terapevticheskii Arkhiv, 91(2), 59–66. https://doi.org/10.26442/00403660.2019.02.000082

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 4

44%

Professor / Associate Prof. 3

33%

Researcher 2

22%

Readers' Discipline

Tooltip

Medicine and Dentistry 5

63%

Psychology 2

25%

Decision Sciences 1

13%

Save time finding and organizing research with Mendeley

Sign up for free